News Roche, Boehringer tap biosensor firms for patient studies Roche and Boehringer Ingelheim have both formed partnerships with tech companies this week to develop and deploy wearable biosensor te
News Lexicon's type 1 diabetes drug voted down by FDA adcomm It has been five years since Lexicon Pharma's type 1 diabetes therapy, Zynquista, was rejected by the FDA, and it may struggle to have a better outcome at its second attempt.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.